A European view on the North American Fifth Consensus on antithrombotic therapy

被引:34
作者
Verstraete, M
Prentice, CRM
Samama, M
Verhaeghe, R
机构
[1] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium
[2] Univ Leeds, Div Med, Leeds LS2 9JT, W Yorkshire, England
[3] Hotel Dieu Paris, Dept Hematol Biol, Paris, France
关键词
antithrombotic agents; coumarin drugs; heparin; warfarin;
D O I
10.1378/chest.117.6.1755
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
An American-Canadian group of experts have, in the November 1998 issue of CHEST, published for the fifth time their recommendations for antithrombotic therapy. This remarkable consensus document was the result of an extensive review of the literature by an interdisciplinary group, Considering the impact. of this document on medical practice, also outside North America, a group, of European experts reviewed in detail the fifth report, particularly the sections on clinical indications of antithrombotic treatment. The aim was not to indicate the many areas of agreement and to quote literature that has become available since publication of the last consensus documents, hut rather to refer to the gray zones of uncertainty and limited number of divergent opinions.
引用
收藏
页码:1755 / 1770
页数:18
相关论文
共 100 条
[1]   Antithrombotic and thrombolytic therapy for ischemic stroke [J].
Albers, GW ;
Easton, JD ;
Sacco, RL ;
Teal, P .
CHEST, 1998, 114 (05) :683S-698S
[2]  
Albers GW, 1999, STROKE, V30, P244
[3]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[4]  
[Anonymous], 1988, LANCET, V1, P921
[5]  
[Anonymous], 1988, LANCET, V2, P349
[6]  
[Anonymous], 1994, BMJ
[7]   Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction - Results of the thrombolysis in myocardial infarction (TIMI) 11B trial [J].
Antman, EM ;
McCabe, CH ;
Gurfinkel, EP ;
Turpie, AGG ;
Bernink, PJLM ;
Salein, D ;
de Luna, AB ;
Fox, K ;
Lablanche, JM ;
Radley, D ;
Premmereur, J ;
Braunwald, E .
CIRCULATION, 1999, 100 (15) :1593-1601
[8]  
Antman EM, 1999, CIRCULATION, V100, P498
[9]   CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION [J].
BAMFORD, J ;
SANDERCOCK, P ;
DENNIS, M ;
BURN, J ;
WARLOW, C .
LANCET, 1991, 337 (8756) :1521-1526
[10]  
Bazzino O, 1998, NEW ENGL J MED, V338, P1488